BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22286757)

  • 1. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
    Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
    Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
    Pancione M; Sabatino L; Fucci A; Carafa V; Nebbioso A; Forte N; Febbraro A; Parente D; Ambrosino C; Normanno N; Altucci L; Colantuoni V
    PLoS One; 2010 Dec; 5(12):e14229. PubMed ID: 21151932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
    Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
    Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
    Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
    Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of
    Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
    Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
    Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
    Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
    Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
    FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties.
    Kong X; Chen J; Xie W; Brown SM; Cai Y; Wu K; Fan D; Nie Y; Yegnasubramanian S; Tiedemann RL; Tao Y; Chiu Yen RW; Topper MJ; Zahnow CA; Easwaran H; Rothbart SB; Xia L; Baylin SB
    Cancer Cell; 2019 Apr; 35(4):633-648.e7. PubMed ID: 30956060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
    Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis.
    Zhu M; Xu Y; Ge M; Gui Z; Yan F
    Cancer Sci; 2015 Jul; 106(7):833-9. PubMed ID: 25940709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.
    Alhosin M; Omran Z; Zamzami MA; Al-Malki AL; Choudhry H; Mousli M; Bronner C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):174. PubMed ID: 27839516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
    Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
    Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
    Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
    Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
    Ogino S; Shima K; Baba Y; Nosho K; Irahara N; Kure S; Chen L; Toyoda S; Kirkner GJ; Wang YL; Giovannucci EL; Fuchs CS
    Gastroenterology; 2009 Apr; 136(4):1242-50. PubMed ID: 19186181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.
    Zhang Y; Huang Z; Zhu Z; Zheng X; Liu J; Han Z; Ma X; Zhang Y
    PLoS One; 2014; 9(10):e104252. PubMed ID: 25272010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UHRF1 expression is upregulated and associated with cellular proliferation in colorectal cancer.
    Kofunato Y; Kumamoto K; Saitou K; Hayase S; Okayama H; Miyamoto K; Sato Y; Katakura K; Nakamura I; Ohki S; Koyama Y; Unoki M; Takenoshita S
    Oncol Rep; 2012 Dec; 28(6):1997-2002. PubMed ID: 23023523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UHRF1 Induces Methylation of the
    Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
    Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
    Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
    Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.